Mar 2, 2011 By: yunews
American Association for Cancer Research Honors Einstein's Susan Band Horowitz
The American Association for Cancer Research (AACR), the world鈥檚 largest organization dedicated to cancer research, has awarded , the Rose C. Falkenstein Professor of Cancer Research and co-chair of molecular pharmacology at of 糖心破解版, its Eighth Award for Lifetime Achievement in Cancer Research.
Dr. Horwitz, who is also the associate director for experimental therapeutics at the , is being honored for her pioneering research that established the mechanism of action of the cancer chemotherapeutic drug Taxol, also known as paclitaxel, which prompted the development of this drug as an important therapy for many common solid tumors. Taxol has been used by more than one million patients worldwide to treat cancers of the ovary, breast and lung.
鈥淒r. Horwitz has had a direct impact on millions of cancer patients around the world through her work in understanding the mechanisms of action of paclitaxel and other cytotoxic drugs,鈥 said Margaret Foti, Ph.D., M.D. (h.c.), chief executive officer of the AACR. 鈥淗er remarkable career and pivotal scientific contributions have influenced our understanding of how cancer drugs work and how to translate that knowledge into improved strategic treatments.鈥
鈥淭his award has great meaning for me because it results from a decision made by my peers,鈥 said Dr. Horwitz. 鈥淭his honor recognizes my laboratory and all of the students, fellows and visiting scientists, who have contributed so much to my research program.鈥
